InvestorsHub Logo
Followers 8
Posts 147
Boards Moderated 0
Alias Born 06/17/2013

Re: cvinvestor post# 9961

Tuesday, 03/03/2015 2:06:44 PM

Tuesday, March 03, 2015 2:06:44 PM

Post# of 118424
Good post. Want to make sure we are on the same page though.

On 9/10 PR stated: 'The Company was informed that before it is cleared to initiate a clinical trial, it must submit additional safety data from experiments conducted in a GLP certified laboratory'.

On 1/14 PR stated: 'Currently FDA is reviewing protocols submitted by the Company for conducting an additional GLP safety study before clinical trials can begin'.

That 1/14 PR is almost 2 months old. I don't see any other company information regarding HemaXellerate since 1/14.

In those 2 months that have passed, do you think it's possible protocol has been approved and those GLP tests are underway as of today? My thought is the company wouldn't announce that they were, as although that may indicate progress to some, most investors would just view it as another fluff PR. Perhaps this is closer than one may think given some of the other events that have happened since the 1/14 PR.

I don't know either way, but I'm just thinking (or hoping) RGBP is closer than you infer. Thoughts?